MedWellAI, Inc. filed a Certificate of Amendment with the Nevada Secretary of State on April 16, 2026. The amendment increases the authorized number of shares for the Series B Convertible Preferred Stock from 1,000,000 to 1,500,000. The change was approved by the holders of 90% of the outstanding Series B Preferred Stock as required by the original Certificate of Designation. The par value and stated value per share remain unchanged at $0.001.